Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

401
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
401
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

321
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
321
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

1.3K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

621
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
621
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

2.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

440
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
440

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Dysautonomia and Sudden Cardiac Death in Parkinson's Disease: Emerging Clinical Insights and Implications for Care.

Cardiology in review·2026
Same author

From Mobile Army Surgical Hospital Units to Street Medicine: Implications for Veterans Experiencing Homelessness.

Military medicine·2026
Same author

Coronary Microvascular Dysfunction in Cardiovascular Disease: Diagnosis and Management.

Cardiology in review·2026
Same author

Shock: Pathophysiology, Classification, and the Role of Lactate in Diagnosis and Prognosis.

Cardiology in review·2026
Same author

Coronary Artery Spasm: Pathophysiology, Diagnosis, and Clinical Implications.

Cardiology in review·2026
Same author

Sudden Death in Children and Young Adults: Etiologies, Risk Stratification, and Prevention Strategies.

Cardiology in review·2025
Same journal

Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice.

Cardiology in review·2026
Same journal

Cardiovascular Manifestations of Epilepsy.

Cardiology in review·2026
Same journal

Finerenone and Cardiorenal Outcomes: A Narrative Review.

Cardiology in review·2026
Same journal

Role of Polypeptide Procalcitonin in Cardiac and Microvascular Injury in Sepsis, Myocardial Ischemia/Reperfusion, Cardiac Arrest, Mixed Shock, and Stress.

Cardiology in review·2026
Same journal

Do Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict In-Hospital and Long-Term Mortality in Endocarditis Patients?: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
Same journal

Pacing for Pressure: The Clinical Efficacy of AVIM Therapy in Hypertension Management.

Cardiology in review·2026
See all related articles

Related Experiment Video

Updated: Jan 1, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.0K

Sarcopenia and Cardiac Dysfunction.

Alexandra Wong1, William Frishman2

  • 1From the Department of Medicine, University of Southern California, Los Angeles, CA.

Cardiology in Review
|December 24, 2019
PubMed
Summary
This summary is machine-generated.

Sarcopenia, or age-related muscle loss, worsens outcomes in heart failure patients. While exercise is key, new therapies are needed to combat muscle wasting and improve quality of life.

More Related Videos

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.0K
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.5K

Related Experiment Videos

Last Updated: Jan 1, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.0K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.0K
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.5K

Area of Science:

  • Gerontology
  • Cardiology
  • Muscle Physiology

Background:

  • Sarcopenia, characterized by muscle mass and strength loss, is common in aging and linked to disability and mortality.
  • Heart failure patients frequently experience sarcopenia, diminishing their quality of life and exercise capacity.
  • Inflammation is a key factor in sarcopenia development within heart failure, necessitating further research into its pathophysiology.

Purpose of the Study:

  • To explore the pathophysiology of muscle wasting in heart failure patients.
  • To identify potential therapeutic targets for sarcopenia in heart failure.
  • To evaluate the role of sarcopenia as a predictor of outcomes post-transcatheter aortic valve replacement.

Main Methods:

  • Review of existing literature on sarcopenia in aging and heart failure.
  • Analysis of inflammatory pathways implicated in muscle wasting.
  • Examination of studies on therapeutic interventions, including physical exercise.
  • Assessment of data on sarcopenia as a prognostic marker after transcatheter aortic valve replacement.

Main Results:

  • Physical exercise is identified as the primary beneficial intervention for sarcopenia in heart failure.
  • Inflammation is a central mechanism underlying muscle wasting in this population.
  • Sarcopenia demonstrates potential as a measurable predictor of outcomes following transcatheter aortic valve replacement.

Conclusions:

  • Further research, particularly randomized clinical trials, is required to explore novel therapeutic interventions beyond exercise for sarcopenia in heart failure.
  • Understanding the pathophysiology of muscle wasting is crucial for developing effective treatments.
  • Sarcopenia assessment may offer valuable prognostic information for patients undergoing transcatheter aortic valve replacement.